Routine Form 3 filing for a new Section 16 officer — no trading signal. Monitor for future Form 4 filings that would indicate open-market purchases or sales by the CFO.
Price Chart
Executive Summary
Form 3 initial beneficial ownership filing for Michael Secora, newly appointed CFO & Chief Corporate Development Officer of Iambic Therapeutics. The filing discloses existing holdings including common stock, convertible preferred shares, and stock options, but contains no transaction or material corporate event.
Key Facts
- Michael Secora appointed CFO & Chief Corp Dev Ofcr at Iambic Therapeutics
- Reports beneficial ownership of 190,160 shares of Common Stock
- Holds 61,342 shares of Series B-3 Convertible Preferred Stock (convertible 1:1 into Common Stock upon IPO)
- Holds options to purchase 190,161 shares at $7.31 (expiring 2035-01-08) and 9,508 shares at $8.73 (expiring 2036-03-03)
- Filing is a routine initial ownership statement under Section 16 — no transaction or price discovery
Financial Impact
No financial impact — routine insider onboarding filing with no transaction or material disclosure
Risk Factors
- No material risks identified from this filing
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001855980-26-000005 |
| Document: 0001855980-26-000005-index-headers.html | 0001855980-26-000005 |
| Document: 0001855980-26-000005-index.html | 0001855980-26-000005 |
| Document: 0001855980-26-000005.txt | 0001855980-26-000005 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | Insider Buy | $16.01 $15.80 | ▼ −1.31% | ▼ −1.84% | $14.41 (−9.99%) |
Oct 16, 2026 10d ago | 8-K | $16.34 $16.01 | ▼ −2.02% | ▼ −2.35% | $14.41 (−11.81%) |
Oct 15, 2026 11d ago | 424B4 | $23.81 $16.34 | ▼ −31.37% | ▼ −31.80% | $14.41 (−39.48%) |
Oct 15, 2026 11d ago | EFFECT | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.41 (−23.80%) |
Oct 14, 2026 11d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.41 (−23.80%) |
Oct 14, 2026 11d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.41 (−23.80%) |
Oct 14, 2026 11d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.41 (−23.80%) |
Oct 14, 2026 11d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.41 (−23.80%) |
Oct 14, 2026 11d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.41 (−23.80%) |
Oct 14, 2026 11d ago | 3 | $18.91 $23.81 | ▲ +25.91% | ▲ +27.02% | $14.41 (−23.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers